The estimated Net Worth of John J Mcdonough is at least $1.01 Milion dollars as of 26 April 2016. John Mcdonough owns over 1,000 units of American Renal Associates stock worth over $1,007,901 and over the last 9 years John sold ARA stock worth over $0.
Sign up
John Mcdonough ARA stock SEC Form 4 insiders trading
John has made over 1 trades of the American Renal Associates stock since 2016, according to the Form 4 filled with the SEC. Most recently John bought 1,000 units of ARA stock worth $22,000 on 26 April 2016.
The largest trade John's ever made was buying 1,000 units of American Renal Associates stock on 26 April 2016 worth over $22,000. On average, John trades about 1,000 units every 0 days since 2016. As of 26 April 2016 John still owns at least 28,044 units of American Renal Associates stock.
You can see the complete history of John Mcdonough stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's John Mcdonough's mailing address?
John's mailing address filed with the SEC is C/O ARAH, INC., 500 CUMMINGS CENTER, BEVERLY, MA, 01915.
Insiders trading at American Renal Associates
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci a Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
What does American Renal Associates's logo look like?
Complete history of John Mcdonough stock trades at American Renal Associates
American Renal Associates executives and stock owners
American Renal Associates executives and other stock owners filed with the SEC include:
-
Don Williamson,
Chief Operating Officer, Executive Vice President -
Thomas Erickson,
Independent Director -
Joseph Carlucci,
Chairman of the Board, Chief Executive Officer, Co-Founder -
Syed Kamal,
President, Co-Founder, Director -
John Jureller,
Independent Director -
Michael Boxer,
Independent Director -
Robert Fish,
Independent Director -
Christopher Hocevar,
Independent Director -
Jeremy Gelber,
Independent Director -
Darren Lehrich,
SVP Strategy & Investor Relations -
Jared Hendricks,
Independent Director -
Susanne Clark,
Independent Director -
Mark Herbers,
Interim Chief Financial Officer, Interim Chief Accounting Officer -
Jason Boucher,
Former VP & CFO -
Patrick T Ryan,
Director -
John J Mcdonough,
EVP, COO AND TREASURER -
Michael Ray Costa,
VP and General Counsel -
Jonathan L Wilcox,
VP & Chief Financial Officer -
Victoria Labriola,
VP and General Counsel -
Capital Partners L Pcenterb...,